Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptide
Our results strongly suggest that a peptide-based active immunotherapy against CGRP could provide an affordable and convenient therapeutic for the prevention of migraine.
Authors
- Shixia Wang (ORCID: https://orcid.org/0000-0002-7748-8468)
- Justin D. Boyd (ORCID: https://orcid.org/0000-0002-5197-4724)
- Madeline M. Vroom (ORCID: https://orcid.org/0000-0002-7560-359X)
- Jeanne K. Brooks (ORCID: https://orcid.org/0009-0002-4219-9591)
- Jean‐Cosme Dodart (ORCID: https://orcid.org/0000-0002-6455-514X)
- Shuang Ding (ORCID: https://orcid.org/0000-0002-9810-8428)
- Jonathan Wiggins
- Jaya Sahni (ORCID: https://orcid.org/0000-0002-5373-6084)
- Yu Sun (ORCID: https://orcid.org/0000-0002-1286-1823)
- Zhi Liu (ORCID: https://orcid.org/0000-0001-9340-962X)
- Hanxin Lu
- Matthew S Longo
- Brett A. Thibodeaux
- Hsiao‐Wen Lin
- Yueh-Ting Hsieh
- Yi‐Pin Chang
Institutions
- Merritt College (US)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1038/s43856-025-00870-2
- Citations
- 2
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94